Mast cell stabilization potential of Sitopaladi churna: An ayurvedic formulation
1, 1, 1★★ Corresponding author
- 1Department of Pharmacognosy, Manipal College of Pharmaceutical Sciences, Manipal University, Karnataka, India
CORRESPONDENCE
H. N. Aswatha Ram
Department of Pharmacognosy, Manipal College of Pharmaceutical Sciences, Manipal University, Karnataka, India
Volume 5, Issue 4 · pp. 306-308 · 2013 · DOI: 10.4103/0974-8490.118824
ABSTRACT
Sitopaladi churna (SPC) is a popular polyherbal ayurvedic formulation used in the treatment of allergy and respiratory diseases. The present study was aimed to justify the classical use of antiallergic claim by performing the mast cell stabilizing activity of extracts of SPC. The protective effect of aqueous extract and methanolic extract - of SPC against compound 48/80-induced mast cell degranulation model was carried out. Sitopaladi churna aqueous extract (SPCA) at the dose of 300 mg/kg and Sitopaladi churna methanolic extract (SPCM) at the doses of 150 and 300 mg/kg showed better protection of mast cell degranulation (65%-74%) and were comparable to the standard drug ketotifen (79%), when peritoneal mast cells were treated with compound 48/80. The protection against mast cell degranulation was significant (P < 0.0001). From the above results, it has been justified that SPC can be used to treat allergic disorders.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Makhija, I. K., Shreedhara, C. S., & Ram, H. N. A. (2013). Mast cell stabilization potential of Sitopaladi churna: An ayurvedic formulation. Pharmacognosy Research, 5(4), 306-308. https://doi.org/10.4103/0974-8490.118824
Copyright and licence
© 2013 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0
